Methods of using death receptor agonists and EGFR inhibitors

• 收藏
• 分享

专利权人:

Avi J. Ashkenazi

发明人:

Avi J. Ashkenazi

申请号：

US13136490

公开号：

US20120189573A1

申请日:

2011.08.01

申请国别(地区):

US

年份:

2012

代理人:

摘要：

Methods for using death receptor ligands, such as Apo-2 ligand/TRAIL polypeptides or death receptor antibodies, and EGFR inhibitors to treat pathological conditions such as cancer are provided. Embodiments of the invention include methods of using Apo2L/TRAIL or death receptor antibodies such as DR5 antibodies and DR4 antibodies in combination with EGFR inhibitors, such as Tarceva™.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/